LPCN
LPCN
NASDAQ · Pharmaceuticals

Lipocine Inc

$1.61
+0.08 (+5.23%)
As of Nov 7, 2:38 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +1,105.6% upside
Low Target $13.09
Average Target $19.41
High Target $19.72
Current Price $1.61
Current
$1.61
Target
$19.41
$13.09 $19.41 avg $19.72
Scenario Analysis
Bear Case
$13.09
713.0%
Low target
Base Case
$19.41
+1,105.6%
Avg target
Bull Case
$19.72
+1,124.8%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$12.37
-87.0% from high
52-Week Low
$1.36
+18.4% from low
Target vs 52W High
$19.41
+56.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%